Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Intra-articular steroids have been also practiced since a long time. These agents have a better and safer profile as compared to oral drugs in terms of adverse effects/contraindications of the later. Moreover, Intra-articular steroids impart a better pain relief by delivering and also delays any surgical intervention thereby improving the patient's quality of life.
Without imaging, intra-articular injection has been shown in only 22% of patients so ultrasound, fluoroscopic imaging and computerized tomographic (CT) are required to ensure accuracy. Comparing to other guidance, ultrasound guided injection provides easy, safe, accurate, non-invasive, inexpensive imaging and lacking exposure to radiation.
Technique of ultrasound-guided intra-articular SIJ injection:
On arrival to recovery room, an IV line will be secured, ringer solution will be infused, O2 mask with 3l/min oxygen will be supplemented and RBS will be measured. Intervention will be done at complete aseptic conditions by ultrasound at frequency of 4-5 MHz patient in prone position. The ultrasound transducer will be oriented in a transverse orientation at the level of the sacral hiatus. Here the sacral cornuae are identified. Moving the transducer laterally from here, the lateral edge of the sacrum is now identified. This bony edge is
followed in a cephalad direction with the transducer maintained in a transverse orientation. A second bony contour, the ileum, is now identified. The cleft between both bony contours represented the sacroiliac joint. This will be found at 4.5 cm depth. Real-time imaging will be used to direct a 22G spinal needle into the SIJ, where 2% lidocaine and triamcinolone or methylprednisolone will be injected under direct vision.The needle will be removed, a sterile dressing will be applied .then patient lay down at supine position at least 30 minutes with blood pressure ,pulse ,O2 saturation and adverse effect monitoring .
If the pain will be ≥ 4, NSAID will be given to control the pain in the form of 20 mg piroxicam once daily after meal.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group MTP | Active Comparator | will receive ultrasound-guided intra-articular SIJ injection with 40 mg of methylprednisolone with a uniform dose of 2 mL of 2% lidocaine hydrochloride. |
|
| - Group TMC | Active Comparator | will receive ultrasound-guided intra-articular SIJ injection with 40 mg of Triamcinolone acetonide with a uniform dose of 2 mL of 2% lidocaine hydrochloride . |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sacroiliac joint injection | Drug | Intervention will be done at complete aseptic conditions by ultrasound at frequency of 4-5 MHz patient in prone position. The ultrasound transducer will be oriented in a transverse orientation at the level of the sacral hiatus. Here the sacral cornuae are identified. Moving the transducer laterally from here, the lateral edge of the sacrum is now identified. This bony edge is followed in a cephalad direction with the transducer maintained in a transverse orientation. A second bony contour, the ileum, is now identified. The cleft between both bony contours represented the sacroiliac joint. This will be found at 4.5 cm depth. Real-time imaging will be used to direct a 22G spinal needle into the SIJ, where 2% lidocaine and triamcinolone or methylprednisolone will be injected under direct vision.The needle will be removed, a sterile dressing will be applied |
| Measure | Description | Time Frame |
|---|---|---|
| numerical rating scale at rest and during motion (standing up from a seated position, during stair climbing and walking) | numerical rating scale from 0 = no pain to 10 maximum pain | before injection |
| numerical rating scale at rest and during motion (standing up from a seated position, during stair climbing and walking) | numerical rating scale from 0 = no pain to 10 maximum pain | after 2 weeks from injection |
| numerical rating scale at rest and during motion (standing up from a seated position, during stair climbing and walking) | numerical rating scale from 0 = no pain to 10 maximum pain | after 1 month from injection |
| numerical rating scale at rest and during motion (standing up from a seated position, during stair climbing and walking) | numerical rating scale from 0 = no pain to 10 maximum pain | after 2 months from injection |
| numerical rating scale at rest and during motion (standing up from a seated position, during stair climbing and walking) | numerical rating scale from 0 = no pain to 10 maximum pain | after 3 months from injection |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life | Euroqol group 5 dimension 5 level (EQ-5D-5L) questionnaire | before injection |
| Quality of life | Euroqol group 5 dimension 5 level (EQ-5D-5L) questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yahya Wahba | Recruiting | Al Mansurah | Egypt |
Not provided
| ID | Term |
|---|---|
| D058566 | Sacroiliitis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| after one month of injection |